Literature DB >> 31708247

Sociodemographic disparities in hypertension prevalence: Results from the first Portuguese National Health Examination Survey.

Ana Paula Rodrigues1, Vânia Gaio2, Irina Kislaya2, Sidsel Graff-Iversen3, Eugénio Cordeiro4, Ana Clara Silva5, Sónia Namorado2, Marta Barreto6, Ana Paula Gil7, Liliana Antunes2, Ana Santos2, José Pereira Miguel8, Baltazar Nunes6, Carlos Matias Dias6.   

Abstract

INTRODUCTION: Cardiovascular disease is an important cause of death and disability worldwide, and hypertension is responsible for at least 45% of all deaths due to heart disease and 51% of deaths due to stroke. This study aimed to estimate and describe the distribution of prevalence, awareness, treatment and control of hypertension in the Portuguese population in 2015.
METHODS: A national survey using a representative sample of 4911 individuals residing in Portugal and aged between 25 and 74 years was implemented. Trained nurses performed a health interview and a physical examination, including blood pressure measurement (right arm, three measurements at 1-min intervals). The prevalence of hypertension was stratified by gender, age group, marital status, education, occupation and type of residential area. Associations between hypertension prevalence and sociodemographic factors were assessed using bivariate and multivariate Poisson regression.
RESULTS: The overall hypertension prevalence was 36.0%. The highest rates were observed in males (39.6%), in individuals aged between 65 and 74 years (71.3%), and in those with low levels of education (62.6%) and with no formal occupation (64.5%). Among hypertensive individuals, 69.8% were aware of their condition and 69.4% were under treatment, of whom 71.3% were controlled. Rates of awareness and medical treatment were significantly higher among women and older individuals.
CONCLUSIONS: A large majority of the adult Portuguese population are likely to reach blood pressure levels defined as hypertension in adulthood. Significant differences in hypertension prevalence were found according to gender, age and socioeconomic status, which highlights the importance of population strategies in public health policies.
Copyright © 2019 Sociedade Portuguesa de Cardiologia. Publicado por Elsevier España, S.L.U. All rights reserved.

Entities:  

Keywords:  Awareness; Control; Controlo; Hipertensão; Hypertension; INSEF 2015; Portugal

Mesh:

Year:  2019        PMID: 31708247     DOI: 10.1016/j.repc.2018.10.012

Source DB:  PubMed          Journal:  Rev Port Cardiol (Engl Ed)        ISSN: 2174-2049


  3 in total

1.  Blood Pressure and Tooth Loss: A Large Cross-Sectional Study with Age Mediation Analysis.

Authors:  José João Mendes; João Viana; Filipe Cruz; Dinis Pereira; Sílvia Ferreira; Paula Pereira; Luís Proença; Vanessa Machado; João Botelho; João Rua; Ana Sintra Delgado
Journal:  Int J Environ Res Public Health       Date:  2021-01-02       Impact factor: 3.390

2.  Combining self-reported and objectively measured survey data to improve hypertension prevalence estimates: Portuguese experience.

Authors:  Irina Kislaya; Andreia Leite; Julian Perelman; Ausenda Machado; Ana Rita Torres; Hanna Tolonen; Baltazar Nunes
Journal:  Arch Public Health       Date:  2021-04-08

3.  Socioeconomic inequalities in prevalence, awareness, treatment and control of hypertension: evidence from the PERSIAN cohort study.

Authors:  Mahin Amini; Mahdi Moradinazar; Fatemeh Rajati; Moslem Soofi; Sadaf G Sepanlou; Hossein Poustchi; Sareh Eghtesad; Mahmood Moosazadeh; Javad Harooni; Javad Aghazadeh-Attari; Majid Fallahi; Mohammad Reza Fattahi; Alireza Ansari-Moghaddam; Farhad Moradpour; Azim Nejatizadeh; Mehdi Shahmoradi; Fariborz Mansour-Ghanaei; Alireza Ostadrahimi; Ali Ahmadi; Arsalan Khaledifar; Mohammad Hossien Saghi; Nader Saki; Iraj Mohebbi; Reza Homayounfar; Mojtaba Farjam; Ali Esmaeili Nadimi; Mahmood Kahnooji; Farhad Pourfarzi; Bijan Zamani; Abbas Rezaianzadeh; Masoumeh Ghoddusi Johari; Masoud Mirzaei; Ali Dehghani; Seyed Fazel Zinat Motlagh; Zahra Rahimi; Reza Malekzadeh; Farid Najafi
Journal:  BMC Public Health       Date:  2022-07-22       Impact factor: 4.135

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.